$CUR Headlines
Neuralstem gets FDA okay for depression study 9:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 4:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 4:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 6:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 6:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 2:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 1:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 1:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 2:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 3:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 10:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 9:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 1:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 1:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 5:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 12:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 8:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 11:36 a.m. April 13, 2007 - Greg Presto
An Early Valuation Of Neuralstem's NSI566 9:25 a.m. Today - Seeking Alpha
First Week Of April 19th Options Trading For Neuralstem (CUR) 12:32 p.m. Feb. 25, 2014 - TheStreet.com
Neuralstem Phase 1 Data Gives Hope In ALS 11:46 a.m. Feb. 18, 2014 - Seeking Alpha
StemCells, Inc., And Neuralstem, Inc.: A Side-By-Side Analysis 1:17 p.m. Jan. 31, 2014 - Seeking Alpha
Neuralstem: Sizing Up Potential Key Events Of 2014 8:05 a.m. Jan. 28, 2014 - Seeking Alpha
Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014 9:30 a.m. Jan. 24, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies 2:07 a.m. Jan. 19, 2014 - Seeking Alpha
Neuralstem Reports First Patient Treated In China Stem Cell Trial to Treat Stroke Motor Deficits 8:49 a.m. Jan. 13, 2014 - benzinga.com
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 2:14 p.m. Jan. 10, 2014 - Seeking Alpha
Organovo Currently Has Nothing In The Works For Tissue Implantation -- Its Main Value Driver 11:05 a.m. Jan. 10, 2014 - Seeking Alpha
Vital Stem Cell Data And Development Coming In 2014 4:26 a.m. Jan. 10, 2014 - Seeking Alpha
Positive Signs From Neuralstem's Phase 2 ALS Trial 12:03 p.m. Jan. 6, 2014 - Seeking Alpha
Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way 10:43 a.m. Jan. 5, 2014 - Seeking Alpha
Neuralstem announces offering, shares fall 10:46 a.m. Jan. 3, 2014 - Seeking Alpha
A Glance At Our Winners And Losers In 2013 5:22 p.m. Dec. 31, 2013 - Seeking Alpha
4 Bold Biotech Calls For 2014 9:00 a.m. Dec. 26, 2013 - Seeking Alpha
Athersys (ATHX) in Focus: Stock Moves 6.8% Higher - Tale of the Tape 9:32 a.m. Dec. 16, 2013 - Zacks.com
Neuralstem Inc: My Favorite Biotech Going Into 2014 6:59 p.m. Dec. 8, 2013 - Seeking Alpha
Can The Uptrend Continue for Neuralstem, Inc. (CUR)? - Tale of the Tape 10:34 a.m. Dec. 2, 2013 - Zacks.com
Neuralstem President and CEO to Present NSI-566 Clinical Trials Program Update at BIO CEO & Investor Conference 2014 9:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
RBCC Explores New Contacts in Personalized Medicine and Drug Delivery 7:54 a.m. Jan. 22, 2014 - BusinessWire - BZX
Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase 3:50 p.m. Jan. 13, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke Motor Deficits 9:46 a.m. Jan. 13, 2014 - PR Newswire - PRF
Neuralstem Closes $20 Million Registered Direct Offering 9:00 a.m. Jan. 9, 2014 - PR Newswire
Neuralstem To Raise $19.65 Million In Registered Direct Offering 9:00 a.m. Jan. 3, 2014 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog 12:15 p.m. Dec. 3, 2013 - ACCESSWIRE
RBCC: Stem Cell Breakthrough Could Eliminate Lung Transplants 5:00 a.m. Dec. 3, 2013 - BusinessWire
RBCC Moves Forward With Regenerative Medicine Negotiations 5:00 a.m. Nov. 21, 2013 - BusinessWire
RBCC Narrows List of Regenerative Medicine Targets 5:00 a.m. Nov. 13, 2013 - BusinessWire
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 4:46 p.m. Nov. 12, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog 9:45 a.m. Oct. 31, 2013 - ACCESSWIRE
Dr. Eva Feldman, Principal Investigator, to Give Update on ALS Trial at American Neurological Association Meeting 8:15 a.m. Oct. 10, 2013 - PR Newswire
University Of Michigan Health System Treats Its First Patients In Neuralstem's Phase II ALS Stem Cell Trial 8:15 a.m. Oct. 9, 2013 - PR Newswire
Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress 8:15 a.m. Sept. 26, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog Entitled â??An ounce of action is worth a ton of theoryâ? 2:03 p.m. Sept. 16, 2013 - ACCESSWIRE
First Patient Treated In Phase II Of Neuralstem ALS Stem Cell Trial 8:15 a.m. Sept. 10, 2013 - PR Newswire
Neuralstem To Raise $4 Million In Registered Direct Offering 6:00 a.m. Sept. 5, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog Entitled â??...Meetest for death, the weakest kind of fruit / Drops earliest to the ground, and so let meâ?¦â? 10:01 a.m. Sept. 3, 2013 - ACCESSWIRE
Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference 8:15 a.m. Sept. 3, 2013 - PR Newswire
Neuralstem gets FDA okay for depression study 9:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 4:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 4:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 6:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 6:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 2:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 1:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 1:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 2:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 3:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 10:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 9:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 1:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 1:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 5:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 12:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 8:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 11:36 a.m. April 13, 2007 - Greg Presto
An Early Valuation Of Neuralstem's NSI566 9:25 a.m. Today - Seeking Alpha
First Week Of April 19th Options Trading For Neuralstem (CUR) 12:32 p.m. Feb. 25, 2014 - TheStreet.com
Neuralstem Phase 1 Data Gives Hope In ALS 11:46 a.m. Feb. 18, 2014 - Seeking Alpha
StemCells, Inc., And Neuralstem, Inc.: A Side-By-Side Analysis 1:17 p.m. Jan. 31, 2014 - Seeking Alpha
Neuralstem: Sizing Up Potential Key Events Of 2014 8:05 a.m. Jan. 28, 2014 - Seeking Alpha
Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014 9:30 a.m. Jan. 24, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies 2:07 a.m. Jan. 19, 2014 - Seeking Alpha
Neuralstem Reports First Patient Treated In China Stem Cell Trial to Treat Stroke Motor Deficits 8:49 a.m. Jan. 13, 2014 - benzinga.com
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 2:14 p.m. Jan. 10, 2014 - Seeking Alpha
Organovo Currently Has Nothing In The Works For Tissue Implantation -- Its Main Value Driver 11:05 a.m. Jan. 10, 2014 - Seeking Alpha
Vital Stem Cell Data And Development Coming In 2014 4:26 a.m. Jan. 10, 2014 - Seeking Alpha
Positive Signs From Neuralstem's Phase 2 ALS Trial 12:03 p.m. Jan. 6, 2014 - Seeking Alpha
Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way 10:43 a.m. Jan. 5, 2014 - Seeking Alpha
Neuralstem announces offering, shares fall 10:46 a.m. Jan. 3, 2014 - Seeking Alpha
A Glance At Our Winners And Losers In 2013 5:22 p.m. Dec. 31, 2013 - Seeking Alpha
4 Bold Biotech Calls For 2014 9:00 a.m. Dec. 26, 2013 - Seeking Alpha
Athersys (ATHX) in Focus: Stock Moves 6.8% Higher - Tale of the Tape 9:32 a.m. Dec. 16, 2013 - Zacks.com
Neuralstem Inc: My Favorite Biotech Going Into 2014 6:59 p.m. Dec. 8, 2013 - Seeking Alpha
Can The Uptrend Continue for Neuralstem, Inc. (CUR)? - Tale of the Tape 10:34 a.m. Dec. 2, 2013 - Zacks.com
Neuralstem President and CEO to Present NSI-566 Clinical Trials Program Update at BIO CEO & Investor Conference 2014 9:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
RBCC Explores New Contacts in Personalized Medicine and Drug Delivery 7:54 a.m. Jan. 22, 2014 - BusinessWire - BZX
Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase 3:50 p.m. Jan. 13, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke Motor Deficits 9:46 a.m. Jan. 13, 2014 - PR Newswire - PRF
Neuralstem Closes $20 Million Registered Direct Offering 9:00 a.m. Jan. 9, 2014 - PR Newswire
Neuralstem To Raise $19.65 Million In Registered Direct Offering 9:00 a.m. Jan. 3, 2014 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog 12:15 p.m. Dec. 3, 2013 - ACCESSWIRE
RBCC: Stem Cell Breakthrough Could Eliminate Lung Transplants 5:00 a.m. Dec. 3, 2013 - BusinessWire
RBCC Moves Forward With Regenerative Medicine Negotiations 5:00 a.m. Nov. 21, 2013 - BusinessWire
RBCC Narrows List of Regenerative Medicine Targets 5:00 a.m. Nov. 13, 2013 - BusinessWire
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 4:46 p.m. Nov. 12, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog 9:45 a.m. Oct. 31, 2013 - ACCESSWIRE
Dr. Eva Feldman, Principal Investigator, to Give Update on ALS Trial at American Neurological Association Meeting 8:15 a.m. Oct. 10, 2013 - PR Newswire
University Of Michigan Health System Treats Its First Patients In Neuralstem's Phase II ALS Stem Cell Trial 8:15 a.m. Oct. 9, 2013 - PR Newswire
Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress 8:15 a.m. Sept. 26, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog Entitled â??An ounce of action is worth a ton of theoryâ? 2:03 p.m. Sept. 16, 2013 - ACCESSWIRE
First Patient Treated In Phase II Of Neuralstem ALS Stem Cell Trial 8:15 a.m. Sept. 10, 2013 - PR Newswire
Neuralstem To Raise $4 Million In Registered Direct Offering 6:00 a.m. Sept. 5, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog Entitled â??...Meetest for death, the weakest kind of fruit / Drops earliest to the ground, and so let meâ?¦â? 10:01 a.m. Sept. 3, 2013 - ACCESSWIRE
Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference 8:15 a.m. Sept. 3, 2013 - PR Newswire
